You already have the data. What you're missing is a verdict.
GuruFocus is a serious database and we're not going to pretend otherwise. But what it hands back is a screen full of numbers with the whole of the judgement still to do. We built the other half.
Opens Microsoft's analysis page · free account · no card · or read an analysis first
$549 a year, for one market, non-refundable
Two things send people looking for an alternative to GuruFocus, and neither is the quality of the data. It's the size of the cheque and the fact that it has to be written all at once. Their own reviewers say it: superb for your home market, expensive the moment you need a second one.
And that buys one market. Add Europe and Premium becomes $948 a year. Plus is $1,398, Pro $2,448.
- Billed by the year, auto-renewing, one market at a time
- Their terms: the first term is a minimum of 12 months
- Their terms: once billed, final and non-refundable
- 7-day trial, card up front
or $24.95 a month, cancel whenever you like
- Annual or monthly, your choice, switch either way
- A refund within 14 days of a charge if you haven't really used it
- Cancel in one click, you keep what you paid for to the end of the period
- The research itself stays free whether you subscribe or not
That's $350 a year back against their US price, and the option to try it a month at a time instead of committing twelve. We'd rather you stayed because the thing is useful than because the money is already gone.
Which of the two should you actually use?
Cheaper is not automatically better, and there are people who should keep paying them.
The database
- You live in the guru and fund filings — thousands of investors and funds, cross-referenced. Our Notable Investors reads the same 13F filings, but it isn't that deep, and theirs isn't either until you reach the $1,398 plan.
- You build screens from hundreds of filters and backtest them. Theirs has 500+; ours has 40 and doesn't backtest at all.
- You build your own models and you want a live Excel or Sheets add-in writing into the sheet. We export the full thirty years to CSV, which is not the same thing.
- You need markets we don't cover yet, or you want the mobile app.
Every one of those is a real reason and none of them is solved by paying us less. Genuinely: stay.
The research desk
- You open a company page and think "fine, but so what?" — you want the platform to take a position and defend it.
- You want the call read for you: a verdict on the quarter, and what management promised last time checked against what they delivered.
- You want thirty years of the same numbers arranged to be read, not exported.
- You'd like to pay monthly, or simply to stop paying $549 for the parts you never open.
Read one analysis first. They're free, there's no account wall, and they'll tell you more about us than this page can.
A screener can find it. It can't tell you whether to want it.
Same company, same filings, same month. What arrives on the screen is not the same thing at all.
A snack company that happens to sell soda, and the snacks are six times more profitable than the drinks. It has raised its dividend every year since 1973. But over six years the dividend grew 39% while free cash flow stood still, and it now consumes 100% of the cash the company generates. The dividend is safe. The dividend growth is not.
The written analyses are the part we give away
They're how most people meet us, and they're a bonus. The subscription is everything a company discloses, arranged so it can be read and judged in an afternoon.
Statements, ownership, insider activity, buybacks, dividends, valuation and earnings on one page that reads top to bottom and explains itself as you scroll.
A written verdict on the moat and a Buffett-lens read on the business, with the evidence they rest on shown underneath.
The Moat Screener plus quality and value views across 6,000+ companies. Where is the durability, where is the quality, where is the price wrong.
A verdict on the quarter, the tone of each executive, and the Promise Ledger: what management said last time, checked against what they delivered.
What you own, what it will pay you and when, what reports this week, and the macro backdrop underneath it.
Frameworks, glossary and worked examples, built into the same terminal. A number you can't interpret is decoration.
Nobody is missing any one of these pieces. What nobody has is all of them in the same place, pointed at the same company, at the same time.
Including the rows we lose
Six of these go their way, and we'd rather you heard it here. Every row is about the $549 Premium plan, not about features that only appear at $1,398.
| GuruFocus · Premium | Dividend Line · Premium | |
|---|---|---|
| Price | $549 a year for the US market Each further market is added on top | $199 a year, every market we cover included ◆ ours |
| Monthly billing | Their terms: the first subscription term is a minimum of 12 months | $24.95 a month, cancel anytime ◆ ours |
| If you change your mind | Their terms: once billed, final and non-refundable, no prorated refunds | A refund within 14 days of a charge if you haven't really used it, plus the EU right of withdrawal ◆ ours |
| 30 years of financials | Yes | Yes |
| Insider and politician trades | Yes | Yes |
| Institutional holdings | 144 guru portfolios on Premium The 8,000+ database starts at Plus, $1,398 theirs | Notable Investors, read from the same 13F filings |
| Screener | All-In-One, 500+ filters theirs | 40 fundamental filters and guru presets, plus two screeners built on written verdicts: the Moat Screener and Buffett's Desk |
| Backtesting | Last 5 years on Premium · back to 2006 from $1,398 theirs | — |
| Getting the data out | Unlimited data exports, plus live Excel and Sheets add-ins (2,000 queries on Premium) theirs | CSV export of the full thirty years. No live spreadsheet add-in. |
| Mobile app | Yes theirs | Web only |
| Markets | 100 markets — but you buy them one at a time. The US alone is $549; adding Europe makes it $948 a year theirs | US, Canada, UK and Portugal, all in the one price. More coming. |
| The platform's own verdict on the business | GF Score, GF Value and a Moat Score out of 10, plus quotes from fund managers' letters. No written verdict of its own. | A written moat call and a Buffett-lens read, company by company, with the evidence under it ◆ ours |
| Earnings | Transcripts, estimates and earnings-call summaries | A verdict on the quarter, management's promises checked against what they delivered, and tone read speaker by speaker |
| Long-form written analyses | A news and article feed | Full-length reports with a verdict and a price, free to read, no account |
Their figures were taken from gurufocus.com/membership and their terms of use on 22 September 2026, and ours from our own pricing page. If any of this has gone out of date, write to us and it gets corrected.
Read one and judge it yourself
In full, no account, no email. If they're not better than what you're reading today, nothing else here matters.
Six years of 39% dividend growth on free cash flow that didn't move. The payout now takes every dollar the business makes.
Seven weeks after we put it at $250.41 it sits at $250.50, having changed chief executive and grown revenue 12.9%. Something moved, and it wasn't the moat.
Margins halved and came back, the returning architect put $25M of his own money in, and the fat pitch was $235, not $423.
The questions that actually arrive
Can I keep both?
Of course, and some people should — theirs for the guru filings and the backtests, ours for the reading and the verdicts. If you're cutting one to save money, the honest question is which one you actually opened last month.
Do you cover my market?
United States, Canada, the United Kingdom and Portugal. If you hold Australian, German or Asian companies, we're the wrong tool today and we'd rather you knew that here than after paying.
Is this investment advice?
No. It's research: the accounts, the business, the moat, the dividend, and a price one investor would pay, with the reasoning shown so you can disagree with it.
What happens when you get one wrong?
The old analysis stays published, dated, and the follow-up says so in the first line. A research site that quietly deletes its misses is worth nothing.
Why is it cheaper? What's missing?
Breadth. They have ten times the screener filters, thousands of funds, a hundred markets, backtesting, a live Excel add-in and a mobile app. We cover four markets and read them properly, and what we don't do is charge you again for the second one.
Open one company. Then decide.
The research costs nothing and needs no account. If at the end you'd rather have the database and the $549, you've lost fifteen minutes and we've lost nothing — you were never our customer.
Free to read · monthly billing available · 7-day trial on Premium · cancel in one click